Zdrowie i gospodarka · 29/12/2015
FDA Establishes Public Docket for Clinical Trial Designs in Emerging Infectious Diseases
The FDA is seeking public input on clinical trial designs for emerging infectious diseases, encouraging the submission of research and data to inform the development of new treatments.
Source: Federal Register — Food and Drug AdministrationOpen original release →